CTT Pharmaceutical (PK) Stock Price - CTTH

-0.024 (-16.00%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CTT Pharmaceutical Holdings Inc (PK) CTTH OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.024 -16.0% 0.126 0.1255 0.15 0.1255 0.15 16:21:02
Bid Price Ask Price Spread Spread % News
0.095 0.15 0.055 36.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9 4,074 $ 0.132394 $ 539 34,411 0.10 - 0.58
Last Trade Time Type Quantity Stock Price Currency
15:39:37 899 $ 0.126 USD

CTT Pharmaceutical (PK) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 5.99M 47.57M $ -1.45M - - 24.23M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
278.00 $ - 0.00% - -

more financials information »

CTT Pharmaceutical (PK) News

Loading Messages....

Latest CTTH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTTH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.160.160.1230.147421412,604-0.034-21.25%
1 Month0.,152-0.034-21.25%
3 Months0.180.20650.100.165840826,733-0.054-30.0%
6 Months0.200.580.100.257155336,984-0.074-37.0%
1 Year0.370.580.100.274134431,404-0.244-65.95%
3 Years0.602.170.100.662019442,748-0.474-79.0%
5 Years0.052.170.01070.61946734,3020.076152.0%

CTT Pharmaceutical (PK) Description

CTTH's principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the "Wafer"). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases. The Company believes that its Wafer technology will be one of the first to gain use in major markets such as pain management. The Oral Thin Film (Wafer) formulation is protected by several Canadian and U.S. patents. Aurora Cannabis Inc. has made a strategic investment in in CTT by way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement includes an issuance of warrants enabling Aurora to increase its ownership to 42.5%.

Your Recent History
CTT Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.